Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Kopran Limited

KOPRAN
Current price
225.8 INR -14.21 INR (-5.92%)
Last closed 240.35 INR
ISIN INE082A01010
Sector Healthcare
Industry Drug Manufacturers - General
Exchange National Stock Exchange of India
Capitalization 14 841 072 537 INR
Yield for 12 month -7.61 %
1Y
3Y
5Y
10Y
15Y
KOPRAN
21.11.2021 - 28.11.2021

Kopran Limited, an integrated pharmaceutical company, engages in the manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-acne, anti-infective, anti-thrombotic, antidiabetic, pain management, neuromodular, gastroenterology, and cardiovascular. In addition, the company provides drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is based in Mumbai, India. Address: Parijat House, Mumbai, India, 400018

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6 251.2 INR

P/E ratio

25.0041

Dividend Yield

1.34 %

Current Year

+6 151 734 702 INR

Last Year

+5 515 084 754 INR

Current Quarter

+1 395 684 647 INR

Last Quarter

+1 862 573 118 INR

Current Year

+1 476 208 849 INR

Last Year

+1 926 053 179 INR

Current Quarter

+363 492 660 INR

Last Quarter

+417 998 198 INR

Key Figures KOPRAN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 859 623 808 INR
Operating Margin TTM 10.25 %
PE Ratio 25.0041
Return On Assets TTM 5.52 %
PEG Ratio
Return On Equity TTM 10.95 %
Wall Street Target Price 6 251.2 INR
Revenue TTM 6 376 294 122 INR
Book Value 101.93 INR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 19.2 %
Dividend Yield 1.34 %
Gross Profit TTM 1 894 504 328 INR
Earnings per share 12.3 INR
Diluted Eps TTM 12.3 INR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 296.6 %
Profit Margin 9.31 %

Dividend Analytics KOPRAN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

29 %

Dividend History KOPRAN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 3
Ex Dividend Date 02.09.2024
Forward Annual Dividend Yield 0.98 %
Last Split Factor 3:2
Payout Ratio 24.41 %
Last Split Date 08.04.1994
Dividend Date

Stock Valuation KOPRAN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 25.0041
Forward PE
Enterprise Value Revenue 2.5742
Price Sales TTM 2.3177
Enterprise Value EBITDA 18.0891
Price Book MRQ 3.0183

Financials KOPRAN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators KOPRAN

For 52 weeks

196.25 INR 370.05 INR
50 Day MA 315.61 INR
Shares Short Prior Month
200 Day MA 272.74 INR
Short Ratio
Shares Short
Short Percent